loading
前日終値:
$0.709
開ける:
$0.7097
24時間の取引高:
35,743
Relative Volume:
0.01
時価総額:
$3.37M
収益:
$14.64M
当期純損益:
$-13.74M
株価収益率:
-0.065
EPS:
-10.47
ネットキャッシュフロー:
$-5.04M
1週間 パフォーマンス:
-0.99%
1か月 パフォーマンス:
+15.89%
6か月 パフォーマンス:
-84.35%
1年 パフォーマンス:
-93.43%
1日の値動き範囲:
Value
$0.68
$0.728
1週間の範囲:
Value
$0.676
$0.74
52週間の値動き範囲:
Value
$0.3611
$11.45

Novabay Pharmaceuticals Inc Stock (NBY) Company Profile

Name
名前
Novabay Pharmaceuticals Inc
Name
セクター
Healthcare (1195)
Name
電話
510-899-8800
Name
住所
2000 Powell Street, Suite 1150, Emeryville, CA
Name
職員
86
Name
Twitter
@NovaBayPharma
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
NBY's Discussions on Twitter

NBY を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
NBY 0.7198 3.37M 14.64M -13.74M -5.04M -10.47
VRTX 449.93 115.43B 10.63B -479.80M -1.35B 13.33
REGN 745.69 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 599.22 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.88 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 108.45 24.89B 3.30B -501.07M 1.03B 11.54

Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2019-09-18 開始されました Ladenburg Thalmann Buy
2018-07-06 繰り返されました H.C. Wainwright Buy
2017-11-15 繰り返されました Laidlaw Buy
2017-06-05 開始されました ROTH Capital Buy
2017-03-27 開始されました Laidlaw Buy
2017-02-06 開始されました Rodman & Renshaw Buy
2016-03-07 ダウングレード Maxim Group Buy → Hold
2015-12-14 繰り返されました Maxim Group Buy
2015-04-30 再開されました Maxim Group Buy
2013-03-06 開始されました Ascendiant Capital Markets Strong Buy
2008-01-03 開始されました Dawson James Speculative Buy
すべてを表示

Novabay Pharmaceuticals Inc (NBY) 最新ニュース

pulisher
Nov 15, 2024

NovaBay calls for affirmative vote on asset sale and dissolution - Investing.com

Nov 15, 2024
pulisher
Nov 15, 2024

NovaBay calls for affirmative vote on asset sale and dissolution By Investing.com - Investing.com UK

Nov 15, 2024
pulisher
Nov 14, 2024

NovaBay Pharmaceuticals Reports Q3 2024 Financials Amid Strategic Changes - TipRanks

Nov 14, 2024
pulisher
Nov 11, 2024

NovaBay Pharmaceuticals Reports Third Quarter 2024 Results, Accepts Revised Offer to Sell Avenova Brand - Vision Monday

Nov 11, 2024
pulisher
Nov 09, 2024

NovaBay Pharmaceuticals (NYSE:NBY) Coverage Initiated at StockNews.com - Defense World

Nov 09, 2024
pulisher
Nov 07, 2024

NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results - StockTitan

Nov 07, 2024
pulisher
Nov 07, 2024

NovaBay accepts higher PRN offer, says Refresh deal no longer superior - MSN

Nov 07, 2024
pulisher
Nov 06, 2024

NovaBay agrees to increased offer for eyecare unit - Investing.com

Nov 06, 2024
pulisher
Nov 06, 2024

NovaBay agrees to increased offer for eyecare unit By Investing.com - Investing.com UK

Nov 06, 2024
pulisher
Nov 06, 2024

NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price - StockTitan

Nov 06, 2024
pulisher
Nov 01, 2024

NovaBay Pharmaceuticals : Signs Distribution Agreement With the Biopharm Group - Marketscreener.com

Nov 01, 2024
pulisher
Oct 31, 2024

# NovaBay Pharmaceuticals Considers Acquisition Offer in Recent SEC Filing - Defense World

Oct 31, 2024
pulisher
Oct 29, 2024

NovaBay Pharmaceuticals receives unsolicited offer from Refresh Acquisitions - MSN

Oct 29, 2024
pulisher
Oct 29, 2024

NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC - StockTitan

Oct 29, 2024
pulisher
Sep 26, 2024

NovaBay Pharmaceuticals Signs Definitive Agreement to Sell Its Avenova Assets - Vision Monday

Sep 26, 2024
pulisher
Sep 25, 2024

Novabay Pharmaceuticals Inc (NBY) Stock: A Year of Market Fluctuations - The InvestChronicle

Sep 25, 2024
pulisher
Sep 25, 2024

Before You Invest, Make Sure You Check This Novabay Pharmaceuticals Inc (AMEX: NBY) Analysis - Stocks Register

Sep 25, 2024
pulisher
Sep 25, 2024

Novabay Pharmaceuticals Inc (NBY)’s Market Momentum: Closing Strong at 0.70, Down -5.62 - The Dwinnex

Sep 25, 2024
pulisher
Sep 24, 2024

NovaBay Pharmaceuticals, Inc. announced that it expects to receive $2.83 million in funding from Pioneer Pharma Pte. Ltd. and other investors. - Marketscreener.com

Sep 24, 2024
pulisher
Sep 24, 2024

A new trading data show Novabay Pharmaceuticals Inc (NBY) is showing positive returns. - SETE News

Sep 24, 2024
pulisher
Sep 23, 2024

Kuehn Law Encourages COFS, ARC, RFL, and NBY Investors to Contact Law Firm - PR Newswire

Sep 23, 2024
pulisher
Sep 22, 2024

NovaBay Pharmaceuticals (NYSE:NBY) Now Covered by StockNews.com - Defense World

Sep 22, 2024
pulisher
Sep 20, 2024

What's Going On With NovaBay Pharmaceuticals Shares Friday? - Benzinga

Sep 20, 2024
pulisher
Sep 20, 2024

NBY’s price-to-free cash flow ratio: What it means for investors - US Post News

Sep 20, 2024
pulisher
Sep 20, 2024

NovaBay sells Avenova brand to PRN for $9.5 million - Investing.com

Sep 20, 2024
pulisher
Sep 20, 2024

PRN Nutriceuticals agreed to acquire Assets of Avenova Brand and Business of NovaBay Pharmaceuticals, Inc.. - Marketscreener.com

Sep 20, 2024
pulisher
Sep 20, 2024

NBY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NovaBay Pharmaceuticals, Inc.’s Avenova Brand and Business Is Fair to Shareholders - Business Wire

Sep 20, 2024
pulisher
Sep 20, 2024

NovaBay sells Avenova brand to PRN for $9.5 million By Investing.com - Investing.com South Africa

Sep 20, 2024
pulisher
Sep 20, 2024

NovaBay Pharma Announces Avenova Sale and Planned Dissolution - TipRanks

Sep 20, 2024
pulisher
Sep 20, 2024

Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals - PR Newswire

Sep 20, 2024
pulisher
Sep 20, 2024

NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets - StockTitan

Sep 20, 2024
pulisher
Sep 06, 2024

NovaBay Pharmaceuticals (NYSE:NBY) Earns Hold Rating from Analysts at StockNews.com - Defense World

Sep 06, 2024
pulisher
Sep 02, 2024

Impetigo Drugs Global Strategic Business Report 2024 - GlobeNewswire Inc.

Sep 02, 2024
pulisher
Aug 20, 2024

Was there any good news for Novabay Pharmaceuticals Inc (NBY) stock in the last session? - US Post News

Aug 20, 2024
pulisher
Aug 19, 2024

Novabay Pharmaceuticals Inc Inc. (NBY) Price Performance: The Role of Supply and Demand - The InvestChronicle

Aug 19, 2024
pulisher
Aug 16, 2024

NovaBay Pharmaceuticals (NYSE:NBY) Announces Quarterly Earnings Results - Defense World

Aug 16, 2024
pulisher
Aug 16, 2024

NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q2 2024 Earnings Call Transcript - Insider Monkey

Aug 16, 2024
pulisher
Aug 15, 2024

Novabay Pharmaceuticals Inc (NBY)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex

Aug 15, 2024
pulisher
Aug 15, 2024

NovaBay Pharmaceuticals Reports Mixed Second Quarter 2024 Financial Results - Vision Monday

Aug 15, 2024
pulisher
Aug 14, 2024

Earnings call: NovaBay Pharmaceuticals reports growth in eyecare By Investing.com - Investing.com Canada

Aug 14, 2024
pulisher
Aug 14, 2024

Earnings call: NovaBay Pharmaceuticals reports growth in eyecare - Investing.com

Aug 14, 2024
pulisher
Aug 14, 2024

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Stock Crosses Above 50-Day Moving Average of $0.00 - Defense World

Aug 14, 2024
pulisher
Aug 14, 2024

NovaBay To Hold 2017 Second Quarter Conference Call On August 10, 2017 - BioSpace

Aug 14, 2024
pulisher
Aug 13, 2024

NBY Stock Earnings: NovaBay Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 - InvestorPlace

Aug 13, 2024
pulisher
Aug 13, 2024

NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results - wallstreet:online

Aug 13, 2024
pulisher
Aug 09, 2024

Ratio Analysis: Unpacking Novabay Pharmaceuticals Inc (NBY)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Aug 09, 2024
pulisher
Aug 09, 2024

NBY’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Aug 09, 2024
pulisher
Aug 07, 2024

NovaBay stock hits 52-week low at $0.47 amid steep annual decline - Investing.com

Aug 07, 2024
pulisher
Aug 02, 2024

NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering - Vision Monday

Aug 02, 2024
pulisher
Aug 01, 2024

NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024 - StockTitan

Aug 01, 2024
pulisher
Jul 31, 2024

Adversity is less terrifying than hope: Novabay Pharmaceuticals Inc (NBY) - SETE News

Jul 31, 2024

Novabay Pharmaceuticals Inc (NBY) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):